Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Bases de datos
Tipo del documento
Asunto de la revista
País de afiliación
Intervalo de año de publicación
1.
Opt Express ; 20(26): B608-14, 2012 Dec 10.
Artículo en Inglés | MEDLINE | ID: mdl-23262909

RESUMEN

DFTS-OFDM has been proposed recently as an alternative to coherent optical OFDM due to its improved transmission performance. This paper proposes spectral shaping for DFTS-OFDM which reduces the PAPR leading to further improvement in nonlinear tolerance. It is shown that for both SSMF and LEAF, the optimized spectrally shaped DFTS-OFDM outperforms DFTS-OFDM for dispersion managed and unmanaged links by ~10.8% and ~6.8%, respectively. The number of bands and the excess bandwidth parameters are also investigated to optimize the transmission performance.

2.
Commun Biol ; 4(1): 44, 2021 01 08.
Artículo en Inglés | MEDLINE | ID: mdl-33420283

RESUMEN

Bispecific T cell engaging antibodies (BiTEs) address tumor associated antigens that are over-expressed on cancer but that can also be found on healthy tissues, causing substantial on-target/off-tumor toxicities. To overcome this hurdle, we recently introduced hemibodies, a pair of complementary antibody fragments that redirect T cells against cancer-defining antigen combinations. Here we show that hemibodies addressing CD38 and SLAMF7 recruit T cells for the exquisite elimination of dual antigen positive multiple myeloma cells while leaving single antigen positive bystanders unharmed. Moreover, CD38 and SLAMF7 targeting BiTEs, but not hemibodies induce massive cytokine release and T cell fratricide reactions, a major drawback of T cell recruiting strategies. Together, we provide evidence in vitro and in vivo that hemibodies can be developed for the effective and highly specific immunotherapy of multiple myeloma.


Asunto(s)
ADP-Ribosil Ciclasa 1/inmunología , Inmunoterapia/métodos , Glicoproteínas de Membrana/inmunología , Mieloma Múltiple/terapia , Familia de Moléculas Señalizadoras de la Activación Linfocitaria/inmunología , ADP-Ribosil Ciclasa 1/metabolismo , Línea Celular Tumoral , Humanos , Glicoproteínas de Membrana/metabolismo , Mieloma Múltiple/metabolismo , Familia de Moléculas Señalizadoras de la Activación Linfocitaria/metabolismo
3.
Genome Med ; 10(1): 3, 2018 01 09.
Artículo en Inglés | MEDLINE | ID: mdl-29310717

RESUMEN

BACKGROUND: Glycosylphosphatidylinositol biosynthesis defects (GPIBDs) cause a group of phenotypically overlapping recessive syndromes with intellectual disability, for which pathogenic mutations have been described in 16 genes of the corresponding molecular pathway. An elevated serum activity of alkaline phosphatase (AP), a GPI-linked enzyme, has been used to assign GPIBDs to the phenotypic series of hyperphosphatasia with mental retardation syndrome (HPMRS) and to distinguish them from another subset of GPIBDs, termed multiple congenital anomalies hypotonia seizures syndrome (MCAHS). However, the increasing number of individuals with a GPIBD shows that hyperphosphatasia is a variable feature that is not ideal for a clinical classification. METHODS: We studied the discriminatory power of multiple GPI-linked substrates that were assessed by flow cytometry in blood cells and fibroblasts of 39 and 14 individuals with a GPIBD, respectively. On the phenotypic level, we evaluated the frequency of occurrence of clinical symptoms and analyzed the performance of computer-assisted image analysis of the facial gestalt in 91 individuals. RESULTS: We found that certain malformations such as Morbus Hirschsprung and diaphragmatic defects are more likely to be associated with particular gene defects (PIGV, PGAP3, PIGN). However, especially at the severe end of the clinical spectrum of HPMRS, there is a high phenotypic overlap with MCAHS. Elevation of AP has also been documented in some of the individuals with MCAHS, namely those with PIGA mutations. Although the impairment of GPI-linked substrates is supposed to play the key role in the pathophysiology of GPIBDs, we could not observe gene-specific profiles for flow cytometric markers or a correlation between their cell surface levels and the severity of the phenotype. In contrast, it was facial recognition software that achieved the highest accuracy in predicting the disease-causing gene in a GPIBD. CONCLUSIONS: Due to the overlapping clinical spectrum of both HPMRS and MCAHS in the majority of affected individuals, the elevation of AP and the reduced surface levels of GPI-linked markers in both groups, a common classification as GPIBDs is recommended. The effectiveness of computer-assisted gestalt analysis for the correct gene inference in a GPIBD and probably beyond is remarkable and illustrates how the information contained in human faces is pivotal in the delineation of genetic entities.


Asunto(s)
Citometría de Flujo/métodos , Glicosilfosfatidilinositoles/biosíntesis , Procesamiento de Imagen Asistido por Computador , Anomalías Múltiples/metabolismo , Automatización , Biomarcadores/metabolismo , Humanos , Discapacidad Intelectual/metabolismo , Fenotipo , Trastornos del Metabolismo del Fósforo/metabolismo , Síndrome
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA